|
|
|
|
|
| September 15, 2011 | ISSUE NUMBER 217 VOL 8 |
Strategy
Mission Critical: Innovation and American Business
Safi Bahcall, CEO at Synta Pharmaceuticals and a member of the Obama Administration’s President’s Council of Advisors on Science and Technology (PCAST), talks with Pharm Exec about the role of innovation in creating jobs and lowering healthcare costs ...Read More
Special Report
The HCR Taxman Cometh
The HCR chit that the industry signed in Washington, D.C. during the summer of 2009 has come due, and it’s time to begin paying up. If your company does more than $5 million a year in sales to various federal government entities, you should read on ...Read More
Vaccines
Bright Future, Big Molecules
Producing vaccines could be a key strategy for firms that have invested in biopharmaceutical manufacturing capacity. The world market for preventative vaccines rose from $22.1 billion in 2009 to $25.3 billion in 2010. It predicts that the market will grow at a compound annual rate of 9.3% during the next five years, thanks partly to sales in emerging markets ...Read More
Diagnostics
Clearing the Hidden Hurdle in Cancer Cures
Diagnostics can boost the efficacy of drug treatments, but delivering the promise depends on a predictable pathway to reimbursement, writes Pfizer's Don Creighton ...Read more
Regulatory
FDA Regulations "Do As Much Harm As Good"
Following on Texas Gov. Rick Perry’s call for “some provocative language in this country” during last week’s GOP debate at the Reagan Library, Rep. Ron Paul (R-Texas) said federal drug regulations “don’t take good care of us" ...Read more
Leadership
Strategies for a Lean Market
In this exclusive podcast, GSK’s Chief Strategy Officer talks about ‘lean management’ and how it can be a driver of innovation ...Listen now
|
|
|
 // Roche has hired Rainer Metternich, PhD, as Head of Small Molecules Research to replace the retiring Klaus Strein, effective immediately. Metternich will will oversee the development of Small Molecules Research's mid- and long-term vision and strategy and guide a group of 800 scientists across Europe and the US as it applies novel technologies to develop world-class compounds. // Wolters Kluwer Pharma Solutions (Phoenix) announced the appointment of Henry Prolog as Vice President, Data Strategy, Acquisitions, and Services. // Catabasis Pharmaceuticals (Cambridge, Mass.) appointed Joanne M. Donovan, MD, PhD, to the position of Chief Medical Officer. //
The Board of Directors of Myrexis (Salt Lake City) appointed current interim President/Chief Executive Officer and Chief Financial Officer (CFO) Robert Lollini as its permanent CEO. Lollini was also appointed as a member of the Board.//
Dr. Peter G. Shields, President of American Society of Preventive Oncology (ASPO), joined The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) as Deputy Director. |
|
|
|
|
|
 |
|
|
|
 |
|
|
|
 |
|
 |
| Does your company's market access strategy embrace the entire product lifecycle? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
